TAK Total Non-Current Liabilities

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · Total Non-Current Liabilities

TAK logo

TAK Total Non-Current Liabilities

Latest reported¥5.34T JPY
TAK Quarterly Total Non-Current Liabilities · JPY (¥226.05B → ¥5.34T)
High-resolution chart · PNG

TAK total non-current liabilities history

Quarterly · JPY. Dates are reporting period ends; fiscal years can differ from calendar years.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) Total Non-Current Liabilities — Quarterly (JPY)
Period endingTotal Non-Current Liabilities (JPY)
5,339,848,000,000
5,271,548,856,000
5,158,018,654,000
5,198,956,000,000
4,968,771,000,000
4,805,844,000,000
5,589,689,000,000
5,264,166,000,000
5,963,248,000,000
5,521,684,000,000
5,198,172,000,000
5,433,247,000,000
5,369,328,000,000
5,121,139,000,000
5,091,398,000,000
5,483,638,000,000
5,581,101,000,000
5,348,765,000,000
5,557,442,000,000
5,317,162,000,000
5,711,809,000,000
5,961,940,000,000
5,841,751,000,000
6,038,587,000,000
5,891,544,000,000
5,917,710,000,000
6,027,910,000,000
6,375,823,000,000
6,669,350,000,000
6,197,803,000,000
2,852,938,000,000
1,258,486,000,000
1,359,559,000,000
1,351,545,000,000
1,398,305,000,000
1,431,489,000,000
1,369,515,000,000
1,040,726,000,000
1,139,675,000,000
1,113,937,000,000
1,124,968,000,000
955,669,000,000
1,016,260,000,000
1,045,535,000,000
1,078,280,000,000
1,073,192,000,000
1,242,586,000,000
1,261,713,000,000
1,242,692,000,000
1,225,755,000,000
1,391,459,000,000
1,359,062,000,000
1,113,577,000,000
1,118,608,000,000
1,088,524,000,000
1,022,684,000,000
791,315,000,000
753,433,000,000
419,476,000,000
437,030,000,000
207,723,000,000
213,150,000,000
212,468,000,000
219,732,000,000
231,371,000,000
230,052,000,000
220,125,000,000
221,194,000,000
234,242,000,000
226,050,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.